1. Home
  2. 2024-09-22
  3. 2024-09-21
  4. 2024-09-20
  5. 2024-09-19
  6. 2019-11-16
  7. 2020-03-31
  8. 2020-05-29
  9. 2021-02-04
  10. 2021-09-05
  11. 2019-05-15
  1. Home
  2. michael deiter pff
  3. PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)

PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)

4.6
(442)
$ 13.00 In stock

Product Description

PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Runcaciguat, C23H22Cl2F3NO3
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
IJMS, Free Full-Text
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Cells, Free Full-Text
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Soluble Guanylate Cyclase Stimulators and Activators
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Femtomolar Sensitivity of a NO Sensor from Clostridium botulinum
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Factors influencing the soluble guanylate cyclase heme redox state in blood vessels - ScienceDirect
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease
PDF) Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY  1101042)
RCSB PDB - 7LGK: Crystal structure of soluble guanylate cyclase activator runcaciguat (BAY 1101042) bound to nostoc H-NOX domain

Related products

You may also like

copyright © 2019-2024 dutchhemp.co.uk all rights reserved.